Skip to content

Median Sevoflurane Concentration for Hypotension Between Young and Elderlypatients: Adaptive Clinical Trial

Comparison of Median Alveolar Sevoflurane Concentration for Hypotension Between Young and Elderly Patients: Adaptive Clinical Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03595319
Enrollment
40
Registered
2018-07-23
Start date
2018-07-23
Completion date
2019-02-15
Last updated
2018-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Keywords

Hypotension, Sevoflurane, Elderly

Brief summary

Two arms: elder group, young group. Dixon's up and down adaptive methodology for ED50. Executed after Anesthesia induction for 10min without touching the patient after starting mechanical ventilation.

Detailed description

This adaptive clinical trial will vary target end tidal sevoflurane by 0.4, then by 0.2 and by 0.1 thereafter in order to minimize sample size.

Interventions

DRUGSevoflurane

Inhaled sevoflurane until allocated dose (see adaptive protocol)

Sponsors

Brasilia University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

Participant will not know allocation (sevoflurane concentration) and will be under general anesthesia

Intervention model description

Adaptive up and down methodology. Anesthesia will be induced using etomidate, rocuronium and remifentanil. After intubation and mechanical ventilation, a high fresh gas flow and variable vaporizer target concentration will be used to stabilize the patient's target end tidal sevoflurane in less than two minutes. Each patient's target end tidal sevoflurane is determined by the concentration used in the previous patient of the same group and by the incidence of hypotension. If the previous patient suffered hypotension, next patient's target concentration will drop. If there was no hypotension, next patient's target concentration will rise. The first patient on each group will be 2%. Target end tidal will vary 0.4% until the first crossover, then drop to 0.2% until the second crossover and will vary 0.1% thereafter.

Eligibility

Sex/Gender
ALL
Age
19 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* Understands experiment, is voluntary, signs informed consent; * Does not take medication that influences arterial pressure; * Normotensive.

Exclusion criteria

* Received any medication that influences arterial pressure before experiment;

Design outcomes

Primary

MeasureTime frameDescription
Hypotension incidence related to sevofluraneDuring the first 10 minutes after end tidal sevoflurane concentration stabilizesAny mean arterial pressure drop \> 10% compared to baseline

Secondary

MeasureTime frameDescription
Systolic hypotensionDuring the first 10 minutes after end tidal sevoflurane concentration stabilizesSystolic arterial pressure drop \>10%
Diastolic hypotensionDuring the first 10 minutes after end tidal sevoflurane concentration stabilizesSystolic arterial pressure drop \>10%

Countries

Brazil

Contacts

Primary ContactGabriel MN Guimarães, MD, MSc
gguimaraes@unb.br+5561996455997

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026